Inventor · disambiguated record
Marianne Langston
Also filed as: LANGSTON MARIANNE
13 granted patents·4 pending applications·110 citations·filing 1995–2021
89Inventor score
Files withMILLENNIUM PHARM INC6DARWIN DISCOVERY LTD2TAKEDA PHARMACEUTICALS CO2ARIAD PHARMA INC1ARMITAGE IAN G1
Top patents by PatentIndex Score
17 records- 0193US6384227B2Racemisation process for use in the manufacture of levobupivacaine and related piperidinecarboxanilide anaesthetic agentsDARWIN DISCOVERY LTD·Filed 2000·Granted May 7, 2002·47 cites·8 claims
- 0288US5994548ACrystallisation of levibupivacaine and analogues thereofDARWIN DISCOVERY LTD·Filed 1995·Granted Nov 30, 1999·50 cites·13 claims
- 0378US10745404B2Process for the synthesis of E1 activating enzyme inhibitorsMILLENNIUM PHARM INC·Filed 2017·Granted Aug 18, 2020·1 cites·7 claims
- 0475US9802938B2Sulfamoylating reagentsMILLENNIUM PHARM INC·Filed 2014·Granted Oct 31, 2017·2 cites·18 claims
- 0574US8933225B2Process for the synthesis of E1 activating enzyme inhibitorsARMITAGE Ian·Filed 2008·Granted Jan 13, 2015·2 cites·14 claims
- 0670US9187482B2Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamateARMITAGE IAN G·Filed 2010·Granted Nov 17, 2015·3 cites·29 claims
- 0768US10016427B2Hydrochloride salt of((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo[2,3-D]pyrimidin-7-YL}-2-hydroxycyclopentyl) methyl sulfamateMILLENNIUM PHARM INC·Filed 2015·Granted Jul 10, 2018·1 cites·23 claims
- 0867US7164025B2Manufacture of single isomer methylphenidateCELLTECH PHARMA EUROP LTD·Filed 2001·Granted Jan 16, 2007·4 cites·8 claims
- 0953US11124519B2Cocrystal forms of ((1S,2S,4R)-4-{4-[(1S)-2,3-dihydro-1H-inden-1-ylamino]-7H-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl) methyl sulfamate, formulations and uses thereofMILLENNIUM PHARM INC·Filed 2018·Granted Sep 21, 2021·0 cites·22 claims
- 1052US12084431B2Pharmaceutical salts of pyrimidine derivatives and method of treating disordersARIAD PHARMA INC·Filed 2019·Granted Sep 10, 2024·0 cites·30 claims
- 1150US2015133460A1Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disordersMILLENNIUM PHAMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1250US2010273808A1Lactate salt of 4-[6-methoxy-7-(3-piperidin-1-yl-propoxy)quinazolin-4-yl]piperazine-1-carboxylic acid(4-isopropoxyphenyl)-amide and pharmaceutical compositions thereof for the treatment of cancer and other diseases or disordersMILLENNIUM PHARMACETICALS INC·Filed 2009·Application pending·0 cites
- 1348US2024368165A1Solid state forms of hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo[2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamateTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 1444US11746109B2Crystalline forms of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6-(3-methyl-1H-pyrazol-4-yl)thieno[3,2-d]pyrimidin-4(3H)-one hemihydrateTAKEDA PHARMACEUTICALS CO·Filed 2017·Granted Sep 5, 2023·0 cites·20 claims
- 1542US2009137579A1Mesylate salt of an IKK inhibitorMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 1641US10072029B2Crystalline form of a proteasome inhibitorMILLENNIUM PHARM INC·Filed 2016·Granted Sep 11, 2018·0 cites·23 claims
- 1740US7482452B2Process for preparing 3-aminothienopyridone derivativesCELLTECH R&D LTD·Filed 2004·Granted Jan 27, 2009·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Marianne Langston files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →